LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C-terminal modified (N-substituted)-2-indolyl dipeptides as inhi

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C-terminal modified (N-substituted)-2-indolyl dipeptides as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C-terminal modified (N-substituted)-2-indolyl dipeptides as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminal modified oxamyl dipeptides as inhibitors of the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminal modified oxamyl dipeptides as inhibitors of the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminal modified oxamyl dipeptides as inhibitors of the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminal modified oxamyl dipeptides as inhibitors of the...

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon

C-terminal peptides of interferon .gamma.

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof

C-terminally truncated dengue and Japanese encephalitis virus en

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon

C-terminally truncated interferon alpha variants

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminus modified heptapeptide LHRH analogs

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...

C-type lectin transmembrane antigen expressed in human...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C.25 [substituted(2-propenyl)]milbemycins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C.sub.3 substituted trioxanes useful as antiparasitic drugs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C.sub.4 -amide substituted compounds and their use as therapeuti

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Biocides; animal or insect repellents or attractants

C.sub.7 -C.sub.12 Diol & Diol alkoxylates as coupling agents for

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C.sup.63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deox

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C1 inhibitor muteins and uses thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C1 to C4 side chain modified nodulisporic acid analogs